Updated just now · Live
Stock analysis, price data, and AI-powered insights for Elevance Health (ELV).
Elevance Health operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ELV.
How to read insider trading filings
Johnson & Johnson
UnitedHealth Group Incorporated
AbbVie Inc.
Merck & Co., Inc.
Eli Lilly and Company
Thermo Fisher Scientific Inc.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ELV Stock Intelligence Report. [stoxpulse.com/stocks/elv]
Disclaimer: The information on this page about Elevance Health (ELV) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Elevance Health.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No earnings data available.
Elevance Health’s Affiliated Health Plans Deliver ...
4h ago
Elevance Health : Affiliated Health Plans Deliver ...
7h ago
StoxPulse AI results for ELV: Pulse Score 50.5/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$81.79B
P/E Ratio
—
EPS
$8.00
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sector
Healthcare
Industry
Managed Health Care
Elevance Health’s Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses
Elevance Health : Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses
B of A Securities Upgrades Elevance Health (ELV)
The Medicaid Pain Is Ending. Buy Elevance Health and These 2 Stocks.
Elevance Health and 2 More Stocks to Buy. Better Days Are Ahead for Medicaid Providers.
Humana Beats Q1 Earnings Estimates on Increasing Premiums
Elevance Health shares are trading higher after B of A Securities upgraded its rating on the stock from Neutral to Buy and raised its price target from $405 to $435.
Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls